JBT-101
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Corbus Pharmaceuticals Inc.
Overview
JBT-101 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
JBT-101 clinical trials
Explore related
Medical disclaimer. This page summarizes research about JBT-101 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.